These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amyotrophic lateral sclerosis--a new role for old drugs. Brown RH N Engl J Med; 2005 Mar; 352(13):1376-8. PubMed ID: 15800236 [No Abstract] [Full Text] [Related]
3. Antibiotics that protect the brain. Secko D CMAJ; 2005 Feb; 172(4):467-8. PubMed ID: 15710934 [No Abstract] [Full Text] [Related]
4. New ideas for therapy in ALS: critical considerations. Beghi E; Bendotti C; Mennini T Amyotroph Lateral Scler; 2006 Jun; 7(2):126-7; discussion 127. PubMed ID: 16753979 [No Abstract] [Full Text] [Related]
5. New career possibilities for certain antibiotics? Eisenstein M Lab Anim (NY); 2005 Feb; 34(2):10. PubMed ID: 15685178 [No Abstract] [Full Text] [Related]
6. Merits of a new drug trial for ALS? Beghi E; Bendotti C; Mennini T Science; 2005 Apr; 308(5722):632-3; author reply 632-3. PubMed ID: 15864832 [No Abstract] [Full Text] [Related]
8. The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice. Chen Z; He Y; Wang ZJ Neurosci Lett; 2012 Feb; 509(2):69-71. PubMed ID: 22212402 [TBL] [Abstract][Full Text] [Related]
9. Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the β-lactam antibiotic, ceftriaxone, in mice. Gunduz O; Oltulu C; Ulugol A Pharmacol Biochem Behav; 2011 Jul; 99(1):100-3. PubMed ID: 21536061 [TBL] [Abstract][Full Text] [Related]
10. Riluzole: what it does to spinal and brainstem neurons and how it does it. Cifra A; Mazzone GL; Nistri A Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264 [TBL] [Abstract][Full Text] [Related]
11. [Neurotransmitter organization of brain and spinal cord motor systems in normal and pathological state]. Barkhatova VP; Zavalishin IA Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):77-82. PubMed ID: 15554148 [No Abstract] [Full Text] [Related]
12. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability. Nicholson KJ; Gilliland TM; Winkelstein BA J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246 [TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685 [TBL] [Abstract][Full Text] [Related]
14. The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury. Wei J; Pan X; Pei Z; Wang W; Qiu W; Shi Z; Xiao G J Trauma Acute Care Surg; 2012 Sep; 73(3):654-60. PubMed ID: 22710775 [TBL] [Abstract][Full Text] [Related]
15. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. Thöne-Reineke C; Neumann C; Namsolleck P; Schmerbach K; Krikov M; Schefe JH; Lucht K; Hörtnagl H; Godes M; Müller S; Rumschüssel K; Funke-Kaiser H; Villringer A; Steckelings UM; Unger T J Hypertens; 2008 Dec; 26(12):2426-35. PubMed ID: 19008722 [TBL] [Abstract][Full Text] [Related]
16. Beta-lactam antibiotics are multipotent agents to combat neurological diseases. Ji HF; Shen L; Zhang HY Biochem Biophys Res Commun; 2005 Aug; 333(3):661-3. PubMed ID: 15907788 [TBL] [Abstract][Full Text] [Related]
17. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide. Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872 [TBL] [Abstract][Full Text] [Related]
18. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611 [TBL] [Abstract][Full Text] [Related]